NMS·Healthcare·$478M·#76 / 520 in Healthcare
KMDA Kamada Ltd.
67SOLID
CATEGORY BREAKDOWN
GROWTH19
QUALITY59
STABILITY99
VALUATION92
GOVERNANCE67
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+12.1%
19
> 50% strong
Gross Margin
Revenue retained after direct costs
42.3%
59
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
4.3%
97
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.6x
92
< 3x strong
Rule of 40
Growth rate plus operating margin
27
60
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
7.2%
51
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.3%
98
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE KMDA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when KMDA's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.